Skip to main content

Table 1 Clinical and demographic characteristics of these patients

From: Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review

Characteristics

Patients for ketamine infusion treatment (n = 22)

Age in years (mean ± SD) 

37.86 ± 16.95

BMI (mean  ± SD)

26.08  ± 6.12

Gender: Female, n (%)

14 (63.64)

Marital status, n (%)

 Never married/divorced

10 (45.45)

 Married/partner

11 (50.00)

 Unknown

1 (4.55)

Race, n (%)

 White

19 (86.36)

 African American

0 (0)

 Hispanic

0 (0)

 Asian

2 (9.09)

 Unknown

1 (4.55)

Educations completed, n (%)

 Grade 6–12 or graduated high school

6 (27.27)

 Graduated 4-year college

10 (45.45)

 Graduate/professional degree

6 (27.27)

 Unknown

0 (0)

Current employment status, n (%)

 Full-time

8 (36.36)

 Part-time

1 (4.55)

 On leave

4 (18.18)

 Retired

1 (4.55)

 Unemployed

5 (22.73)

 Student

3 (13.64)

History of substance use disorder, n (%)

 EtOH use

3 (13.64)

 THC

7 (31.82)

 Illicit substance use

3 (13.64)

Current concomitant psychiatric disorder, n (%)

 Anxiety

10 (45.45)

 PTSD

5 (22.71)

 OCD

2 (9.10)

 ADHD

4 (18.18)

Concomitant medications, n (%)

 Antidepressant drugs

100

 Mood stabilizer

8 (36.36)

 Antipsychotics

10 (45.45)

 Stimulants

6 (27.27)

 Benzodiazepines

10 (45.45)

History of suicidal attempts, n (%)

6 (27.27)

Treatments history of ECT, n (%)

8 (36.36)

Treatments history of TMS, n (%)

7 (31.82)